LA BioMed

Join the mailing list

Check your email and confirm the subscription

08
DEC
2014

Vaccine Holds Hope of Preventing Antibiotic Resistant Skin Infections

 LA BioMed Researchers Find Novel NDV-3 Vaccine Protects Against MRSA LOS ANGELES – (Dec. 8, 2014) – In the U.S. and around the globe, skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) continue to endanger the health and lives of...
08
DEC
2014

EMMAUS LIFE SCIENCES TO PRESENT PHASE 3 SICKLE CELL DISEASE TRIAL DATA AT 56TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

Reduction in the Frequency of Sickle Cell Crisis, Frequency in Hospitalizations, Hospital Days and Fewer Cases of Acute Chest Syndrome Highlighted in Abstract TORRANCE, Calif., November 24, 2014 – Emmaus Life Sciences, Inc. (the “Company,” or “Emmaus”), today announced that Dr....
20
NOV
2014

The Ever-Transcendent Cell

Deriving physiologic first principles Both the developmental and phylogenetic histories of an organism describe the evolution of physiology—the complex of metabolic pathways that govern the function of an organism as a whole. The necessity of establishing and maintaining...
06
NOV
2014

LA BioMed Receives Phase II Grand Challenges Explorations Funding

LOS ANGELES – Los Angeles Biomedical Research Institute (LA BioMed) announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas...
30
OCT
2014

Grant Awarded for Device to Detect Newborn Heart Problems

LA BioMed Partnering with QT Medical to Identify Infants at Risk of Long QT Syndrome LOS ANGELES – (Oct. 28, 2014) –Each year, some 2,000 babies are born in the U.S. with a genetic heart condition, known as long QT syndrome. If not diagnosed in time, babies with long QT syndrome...
20
OCT
2014

Grant awarded for development of therapy for Sanfilippo disease

LOS ANGELES – The National Institute of Neurological Disorders and Stroke recently awarded a grant to Phoenix Nest Inc. to partner with the Los Angeles Biomedical Research Institute (LA BioMed) to investigate the development of a therapy for treating a devastating inherited...
19
OCT
2014

Advancing Innovation Gala to Honor Leaders of Companies Built on LA BioMed Research

Event also Will Recognize Dr. John Michael Criley for His Leadership LOS ANGELES – (September 24, 2014) – On Oct. 18 at its Advancing Innovation Gala, Los Angeles Biomedical Research Institute (LA BioMed) will recognize three champions of innovation who are leading companies...
08
OCT
2014

Universal Screening for MRSA May be Too Costly

Researchers Identify Why Hospitals May Not “Get in the Ring” to Fight “Superbug” PHILADELPHIA – (Oct. 8, 2014) – Numerous experts and policy makers have called for hospitals to screen patients for methicillin-resistant Staphylococcus aureus (MRSA) infections and isolate anyone...
01
OCT
2014

Study Holds Hope of a Treatment For Deadly Genetic Disease, MPS IIIB

Researchers Find Method for Replacing Missing Enzyme in the Brain. LOS ANGELES – (Oct. 1, 2014) – MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death — often...